nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—atherosclerosis	0.815	1	CbGaD
Nabilone—Dronabinol—CNR2—atherosclerosis	0.00605	1	CrCbGaD
Nabilone—Pharyngitis—Rosuvastatin—atherosclerosis	0.00059	0.005	CcSEcCtD
Nabilone—Mood swings—Pravastatin—atherosclerosis	0.000583	0.00494	CcSEcCtD
Nabilone—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000574	0.00486	CcSEcCtD
Nabilone—Orthostatic hypotension—Niacin—atherosclerosis	0.000571	0.00484	CcSEcCtD
Nabilone—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000563	0.00477	CcSEcCtD
Nabilone—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000537	0.00455	CcSEcCtD
Nabilone—Arrhythmia—Rosuvastatin—atherosclerosis	0.000531	0.0045	CcSEcCtD
Nabilone—Depression—Simvastatin—atherosclerosis	0.000523	0.00443	CcSEcCtD
Nabilone—Sweating increased—Pravastatin—atherosclerosis	0.000518	0.00439	CcSEcCtD
Nabilone—Pharyngitis—Ezetimibe—atherosclerosis	0.00049	0.00415	CcSEcCtD
Nabilone—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000486	0.00411	CcSEcCtD
Nabilone—Depression—Pravastatin—atherosclerosis	0.000473	0.00401	CcSEcCtD
Nabilone—Stomatitis—Niacin—atherosclerosis	0.00047	0.00398	CcSEcCtD
Nabilone—Flushing—Lovastatin—atherosclerosis	0.000468	0.00396	CcSEcCtD
Nabilone—Flushing—Ezetimibe—atherosclerosis	0.000459	0.00388	CcSEcCtD
Nabilone—Chills—Lovastatin—atherosclerosis	0.000452	0.00383	CcSEcCtD
Nabilone—Cough—Rosuvastatin—atherosclerosis	0.000452	0.00382	CcSEcCtD
Nabilone—Arthralgia—Rosuvastatin—atherosclerosis	0.000441	0.00373	CcSEcCtD
Nabilone—Myalgia—Rosuvastatin—atherosclerosis	0.000441	0.00373	CcSEcCtD
Nabilone—Flushing—Simvastatin—atherosclerosis	0.000437	0.0037	CcSEcCtD
Nabilone—Hypoaesthesia—Niacin—atherosclerosis	0.00043	0.00365	CcSEcCtD
Nabilone—Confusional state—Rosuvastatin—atherosclerosis	0.000426	0.00361	CcSEcCtD
Nabilone—Back pain—Lovastatin—atherosclerosis	0.000424	0.00359	CcSEcCtD
Nabilone—Hypoaesthesia—Pravastatin—atherosclerosis	0.000424	0.00359	CcSEcCtD
Nabilone—Pharyngitis—Pravastatin—atherosclerosis	0.000423	0.00358	CcSEcCtD
Nabilone—Chills—Simvastatin—atherosclerosis	0.000423	0.00358	CcSEcCtD
Nabilone—Infection—Rosuvastatin—atherosclerosis	0.00042	0.00355	CcSEcCtD
Nabilone—Visual impairment—Niacin—atherosclerosis	0.000417	0.00353	CcSEcCtD
Nabilone—Back pain—Ezetimibe—atherosclerosis	0.000416	0.00352	CcSEcCtD
Nabilone—Vision blurred—Lovastatin—atherosclerosis	0.000413	0.0035	CcSEcCtD
Nabilone—Tremor—Lovastatin—atherosclerosis	0.000411	0.00348	CcSEcCtD
Nabilone—Visual impairment—Pravastatin—atherosclerosis	0.000411	0.00348	CcSEcCtD
Nabilone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000407	0.00345	CcSEcCtD
Nabilone—Eye disorder—Niacin—atherosclerosis	0.000404	0.00342	CcSEcCtD
Nabilone—Tinnitus—Niacin—atherosclerosis	0.000403	0.00342	CcSEcCtD
Nabilone—Flushing—Niacin—atherosclerosis	0.000402	0.0034	CcSEcCtD
Nabilone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000399	0.00338	CcSEcCtD
Nabilone—Anaemia—Ezetimibe—atherosclerosis	0.000398	0.00337	CcSEcCtD
Nabilone—Tinnitus—Pravastatin—atherosclerosis	0.000397	0.00336	CcSEcCtD
Nabilone—Malaise—Lovastatin—atherosclerosis	0.000395	0.00335	CcSEcCtD
Nabilone—Flushing—Pravastatin—atherosclerosis	0.000395	0.00335	CcSEcCtD
Nabilone—Vertigo—Lovastatin—atherosclerosis	0.000394	0.00334	CcSEcCtD
Nabilone—Leukopenia—Lovastatin—atherosclerosis	0.000393	0.00332	CcSEcCtD
Nabilone—Chills—Niacin—atherosclerosis	0.000388	0.00329	CcSEcCtD
Nabilone—Malaise—Ezetimibe—atherosclerosis	0.000388	0.00328	CcSEcCtD
Nabilone—Vision blurred—Simvastatin—atherosclerosis	0.000387	0.00327	CcSEcCtD
Nabilone—Arrhythmia—Niacin—atherosclerosis	0.000387	0.00327	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000385	0.00326	CcSEcCtD
Nabilone—Tremor—Simvastatin—atherosclerosis	0.000384	0.00325	CcSEcCtD
Nabilone—Chills—Pravastatin—atherosclerosis	0.000382	0.00324	CcSEcCtD
Nabilone—Insomnia—Rosuvastatin—atherosclerosis	0.000382	0.00323	CcSEcCtD
Nabilone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000381	0.00322	CcSEcCtD
Nabilone—Arrhythmia—Pravastatin—atherosclerosis	0.000381	0.00322	CcSEcCtD
Nabilone—Palpitations—Ezetimibe—atherosclerosis	0.00038	0.00322	CcSEcCtD
Nabilone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000379	0.00321	CcSEcCtD
Nabilone—Anaemia—Simvastatin—atherosclerosis	0.000379	0.00321	CcSEcCtD
Nabilone—Cough—Ezetimibe—atherosclerosis	0.000375	0.00318	CcSEcCtD
Nabilone—Myalgia—Lovastatin—atherosclerosis	0.000373	0.00316	CcSEcCtD
Nabilone—Arthralgia—Lovastatin—atherosclerosis	0.000373	0.00316	CcSEcCtD
Nabilone—Chest pain—Lovastatin—atherosclerosis	0.000373	0.00316	CcSEcCtD
Nabilone—Anxiety—Lovastatin—atherosclerosis	0.000372	0.00315	CcSEcCtD
Nabilone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000372	0.00315	CcSEcCtD
Nabilone—Hypertension—Ezetimibe—atherosclerosis	0.000371	0.00314	CcSEcCtD
Nabilone—Malaise—Simvastatin—atherosclerosis	0.00037	0.00313	CcSEcCtD
Nabilone—Tension—Niacin—atherosclerosis	0.00037	0.00313	CcSEcCtD
Nabilone—Discomfort—Lovastatin—atherosclerosis	0.000369	0.00312	CcSEcCtD
Nabilone—Vertigo—Simvastatin—atherosclerosis	0.000369	0.00312	CcSEcCtD
Nabilone—Leukopenia—Simvastatin—atherosclerosis	0.000367	0.00311	CcSEcCtD
Nabilone—Myalgia—Ezetimibe—atherosclerosis	0.000366	0.0031	CcSEcCtD
Nabilone—Arthralgia—Ezetimibe—atherosclerosis	0.000366	0.0031	CcSEcCtD
Nabilone—Chest pain—Ezetimibe—atherosclerosis	0.000366	0.0031	CcSEcCtD
Nabilone—Nervousness—Niacin—atherosclerosis	0.000366	0.0031	CcSEcCtD
Nabilone—Dry mouth—Lovastatin—atherosclerosis	0.000365	0.00309	CcSEcCtD
Nabilone—Tension—Pravastatin—atherosclerosis	0.000364	0.00308	CcSEcCtD
Nabilone—Discomfort—Ezetimibe—atherosclerosis	0.000362	0.00306	CcSEcCtD
Nabilone—Pain—Rosuvastatin—atherosclerosis	0.000361	0.00306	CcSEcCtD
Nabilone—Constipation—Rosuvastatin—atherosclerosis	0.000361	0.00306	CcSEcCtD
Nabilone—Confusional state—Lovastatin—atherosclerosis	0.000361	0.00306	CcSEcCtD
Nabilone—Nervousness—Pravastatin—atherosclerosis	0.00036	0.00305	CcSEcCtD
Nabilone—Dry mouth—Ezetimibe—atherosclerosis	0.000358	0.00303	CcSEcCtD
Nabilone—Infection—Lovastatin—atherosclerosis	0.000356	0.00301	CcSEcCtD
Nabilone—Vision blurred—Niacin—atherosclerosis	0.000355	0.00301	CcSEcCtD
Nabilone—Confusional state—Ezetimibe—atherosclerosis	0.000354	0.003	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000353	0.00579	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000351	0.00575	CbGpPWpGaD
Nabilone—Vision blurred—Pravastatin—atherosclerosis	0.000349	0.00296	CcSEcCtD
Nabilone—Arthralgia—Simvastatin—atherosclerosis	0.000349	0.00296	CcSEcCtD
Nabilone—Myalgia—Simvastatin—atherosclerosis	0.000349	0.00296	CcSEcCtD
Nabilone—Chest pain—Simvastatin—atherosclerosis	0.000349	0.00296	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—KNG1—atherosclerosis	0.000349	0.00571	CbGpPWpGaD
Nabilone—Infection—Ezetimibe—atherosclerosis	0.000349	0.00295	CcSEcCtD
Nabilone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000348	0.00295	CcSEcCtD
Nabilone—Anxiety—Simvastatin—atherosclerosis	0.000348	0.00295	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CCL3—atherosclerosis	0.000348	0.0057	CbGpPWpGaD
Nabilone—Tremor—Pravastatin—atherosclerosis	0.000347	0.00294	CcSEcCtD
Nabilone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000345	0.00292	CcSEcCtD
Nabilone—Discomfort—Simvastatin—atherosclerosis	0.000345	0.00292	CcSEcCtD
Nabilone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000344	0.00291	CcSEcCtD
Nabilone—Anaemia—Pravastatin—atherosclerosis	0.000343	0.0029	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CASR—atherosclerosis	0.000342	0.00559	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000342	0.00559	CbGpPWpGaD
Nabilone—Anorexia—Lovastatin—atherosclerosis	0.000341	0.00289	CcSEcCtD
Nabilone—Vertigo—Niacin—atherosclerosis	0.000338	0.00287	CcSEcCtD
Nabilone—Syncope—Niacin—atherosclerosis	0.000338	0.00286	CcSEcCtD
Nabilone—Confusional state—Simvastatin—atherosclerosis	0.000338	0.00286	CcSEcCtD
Nabilone—Leukopenia—Niacin—atherosclerosis	0.000337	0.00285	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000335	0.00548	CbGpPWpGaD
Nabilone—Malaise—Pravastatin—atherosclerosis	0.000334	0.00283	CcSEcCtD
Nabilone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000334	0.00283	CcSEcCtD
Nabilone—Vertigo—Pravastatin—atherosclerosis	0.000333	0.00282	CcSEcCtD
Nabilone—Palpitations—Niacin—atherosclerosis	0.000333	0.00282	CcSEcCtD
Nabilone—Infection—Simvastatin—atherosclerosis	0.000333	0.00282	CcSEcCtD
Nabilone—Leukopenia—Pravastatin—atherosclerosis	0.000332	0.00281	CcSEcCtD
Nabilone—Loss of consciousness—Niacin—atherosclerosis	0.000331	0.0028	CcSEcCtD
Nabilone—Cough—Niacin—atherosclerosis	0.000329	0.00278	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000326	0.00276	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000324	0.00531	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000324	0.00531	CbGpPWpGaD
Nabilone—Insomnia—Lovastatin—atherosclerosis	0.000324	0.00274	CcSEcCtD
Nabilone—Cough—Pravastatin—atherosclerosis	0.000324	0.00274	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000322	0.00527	CbGpPWpGaD
Nabilone—Paraesthesia—Lovastatin—atherosclerosis	0.000321	0.00272	CcSEcCtD
Nabilone—Myalgia—Niacin—atherosclerosis	0.000321	0.00272	CcSEcCtD
Nabilone—Arthralgia—Niacin—atherosclerosis	0.000321	0.00272	CcSEcCtD
Nabilone—Hypertension—Pravastatin—atherosclerosis	0.00032	0.00271	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00032	0.00271	CcSEcCtD
Nabilone—Anorexia—Simvastatin—atherosclerosis	0.000319	0.0027	CcSEcCtD
Nabilone—Dyspnoea—Lovastatin—atherosclerosis	0.000319	0.0027	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CNR2—atherosclerosis	0.000318	0.0052	CbGpPWpGaD
Nabilone—Insomnia—Ezetimibe—atherosclerosis	0.000318	0.00269	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000316	0.00517	CbGpPWpGaD
Nabilone—Chest pain—Pravastatin—atherosclerosis	0.000316	0.00267	CcSEcCtD
Nabilone—Arthralgia—Pravastatin—atherosclerosis	0.000316	0.00267	CcSEcCtD
Nabilone—Myalgia—Pravastatin—atherosclerosis	0.000316	0.00267	CcSEcCtD
Nabilone—Paraesthesia—Ezetimibe—atherosclerosis	0.000315	0.00267	CcSEcCtD
Nabilone—Dyspepsia—Lovastatin—atherosclerosis	0.000315	0.00267	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CCR2—atherosclerosis	0.000315	0.00515	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—EDNRA—atherosclerosis	0.000315	0.00515	CbGpPWpGaD
Nabilone—Anxiety—Pravastatin—atherosclerosis	0.000315	0.00266	CcSEcCtD
Nabilone—Dry mouth—Niacin—atherosclerosis	0.000314	0.00266	CcSEcCtD
Nabilone—Dyspnoea—Ezetimibe—atherosclerosis	0.000313	0.00265	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—HRH1—atherosclerosis	0.000312	0.00512	CbGpPWpGaD
Nabilone—Discomfort—Pravastatin—atherosclerosis	0.000312	0.00264	CcSEcCtD
Nabilone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000311	0.00263	CcSEcCtD
Nabilone—Decreased appetite—Lovastatin—atherosclerosis	0.000311	0.00263	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—AGT—atherosclerosis	0.000311	0.00509	CbGpPWpGaD
Nabilone—Dyspepsia—Ezetimibe—atherosclerosis	0.000309	0.00262	CcSEcCtD
Nabilone—Fatigue—Lovastatin—atherosclerosis	0.000309	0.00261	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—GHRL—atherosclerosis	0.000307	0.00502	CbGpPWpGaD
Nabilone—Constipation—Lovastatin—atherosclerosis	0.000306	0.00259	CcSEcCtD
Nabilone—Pain—Lovastatin—atherosclerosis	0.000306	0.00259	CcSEcCtD
Nabilone—Confusional state—Pravastatin—atherosclerosis	0.000305	0.00258	CcSEcCtD
Nabilone—Decreased appetite—Ezetimibe—atherosclerosis	0.000305	0.00258	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000305	0.00258	CcSEcCtD
Nabilone—Asthenia—Rosuvastatin—atherosclerosis	0.000303	0.00257	CcSEcCtD
Nabilone—Insomnia—Simvastatin—atherosclerosis	0.000303	0.00256	CcSEcCtD
Nabilone—Fatigue—Ezetimibe—atherosclerosis	0.000303	0.00256	CcSEcCtD
Nabilone—Shock—Niacin—atherosclerosis	0.000302	0.00256	CcSEcCtD
Nabilone—Infection—Pravastatin—atherosclerosis	0.000301	0.00255	CcSEcCtD
Nabilone—Paraesthesia—Simvastatin—atherosclerosis	0.000301	0.00255	CcSEcCtD
Nabilone—Constipation—Ezetimibe—atherosclerosis	0.0003	0.00254	CcSEcCtD
Nabilone—Pain—Ezetimibe—atherosclerosis	0.0003	0.00254	CcSEcCtD
Nabilone—Tachycardia—Niacin—atherosclerosis	0.0003	0.00254	CcSEcCtD
Nabilone—Pruritus—Rosuvastatin—atherosclerosis	0.000299	0.00253	CcSEcCtD
Nabilone—Dyspnoea—Simvastatin—atherosclerosis	0.000298	0.00253	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000298	0.00488	CbGpPWpGaD
Nabilone—Hyperhidrosis—Niacin—atherosclerosis	0.000297	0.00252	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000296	0.00484	CbGpPWpGaD
Nabilone—Feeling abnormal—Lovastatin—atherosclerosis	0.000295	0.0025	CcSEcCtD
Nabilone—Dyspepsia—Simvastatin—atherosclerosis	0.000295	0.0025	CcSEcCtD
Nabilone—Anorexia—Niacin—atherosclerosis	0.000293	0.00248	CcSEcCtD
Nabilone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000293	0.00248	CcSEcCtD
Nabilone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000293	0.00248	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CCL5—atherosclerosis	0.000292	0.00478	CbGpPWpGaD
Nabilone—Decreased appetite—Simvastatin—atherosclerosis	0.000291	0.00246	CcSEcCtD
Nabilone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000289	0.00245	CcSEcCtD
Nabilone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000289	0.00245	CcSEcCtD
Nabilone—Fatigue—Simvastatin—atherosclerosis	0.000289	0.00244	CcSEcCtD
Nabilone—Anorexia—Pravastatin—atherosclerosis	0.000288	0.00244	CcSEcCtD
Nabilone—Hypotension—Niacin—atherosclerosis	0.000287	0.00243	CcSEcCtD
Nabilone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000287	0.00243	CcSEcCtD
Nabilone—Pain—Simvastatin—atherosclerosis	0.000286	0.00242	CcSEcCtD
Nabilone—Constipation—Simvastatin—atherosclerosis	0.000286	0.00242	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—HRH1—atherosclerosis	0.000284	0.00465	CbGpPWpGaD
Nabilone—Body temperature increased—Lovastatin—atherosclerosis	0.000283	0.0024	CcSEcCtD
Nabilone—Abdominal pain—Lovastatin—atherosclerosis	0.000283	0.0024	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00028	0.00237	CcSEcCtD
Nabilone—Dizziness—Rosuvastatin—atherosclerosis	0.000279	0.00236	CcSEcCtD
Nabilone—Insomnia—Niacin—atherosclerosis	0.000278	0.00235	CcSEcCtD
Nabilone—Abdominal pain—Ezetimibe—atherosclerosis	0.000278	0.00235	CcSEcCtD
Nabilone—Body temperature increased—Ezetimibe—atherosclerosis	0.000278	0.00235	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000277	0.00454	CbGpPWpGaD
Nabilone—Paraesthesia—Niacin—atherosclerosis	0.000276	0.00234	CcSEcCtD
Nabilone—Feeling abnormal—Simvastatin—atherosclerosis	0.000276	0.00234	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000276	0.00233	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000276	0.00451	CbGpPWpGaD
Nabilone—Dyspnoea—Niacin—atherosclerosis	0.000274	0.00232	CcSEcCtD
Nabilone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000274	0.00232	CcSEcCtD
Nabilone—Insomnia—Pravastatin—atherosclerosis	0.000274	0.00232	CcSEcCtD
Nabilone—Somnolence—Niacin—atherosclerosis	0.000273	0.00231	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CCL3—atherosclerosis	0.000273	0.00447	CbGpPWpGaD
Nabilone—Paraesthesia—Pravastatin—atherosclerosis	0.000272	0.0023	CcSEcCtD
Nabilone—Dyspepsia—Niacin—atherosclerosis	0.000271	0.00229	CcSEcCtD
Nabilone—Dyspnoea—Pravastatin—atherosclerosis	0.00027	0.00228	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—KNG1—atherosclerosis	0.000269	0.00441	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR1—atherosclerosis	0.000268	0.00438	CbGpPWpGaD
Nabilone—Decreased appetite—Niacin—atherosclerosis	0.000267	0.00226	CcSEcCtD
Nabilone—Dyspepsia—Pravastatin—atherosclerosis	0.000266	0.00226	CcSEcCtD
Nabilone—Rash—Rosuvastatin—atherosclerosis	0.000266	0.00225	CcSEcCtD
Nabilone—Dermatitis—Rosuvastatin—atherosclerosis	0.000266	0.00225	CcSEcCtD
Nabilone—Body temperature increased—Simvastatin—atherosclerosis	0.000265	0.00224	CcSEcCtD
Nabilone—Abdominal pain—Simvastatin—atherosclerosis	0.000265	0.00224	CcSEcCtD
Nabilone—Headache—Rosuvastatin—atherosclerosis	0.000265	0.00224	CcSEcCtD
Nabilone—Hypersensitivity—Lovastatin—atherosclerosis	0.000264	0.00223	CcSEcCtD
Nabilone—Decreased appetite—Pravastatin—atherosclerosis	0.000263	0.00223	CcSEcCtD
Nabilone—Pain—Niacin—atherosclerosis	0.000263	0.00223	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCL4—atherosclerosis	0.000261	0.00428	CbGpPWpGaD
Nabilone—Fatigue—Pravastatin—atherosclerosis	0.000261	0.00221	CcSEcCtD
Nabilone—Constipation—Pravastatin—atherosclerosis	0.000259	0.00219	CcSEcCtD
Nabilone—Pain—Pravastatin—atherosclerosis	0.000259	0.00219	CcSEcCtD
Nabilone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000259	0.00219	CcSEcCtD
Nabilone—Asthenia—Lovastatin—atherosclerosis	0.000257	0.00217	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—UTS2—atherosclerosis	0.000257	0.0042	CbGpPWpGaD
Nabilone—Pruritus—Lovastatin—atherosclerosis	0.000253	0.00214	CcSEcCtD
Nabilone—Asthenia—Ezetimibe—atherosclerosis	0.000252	0.00213	CcSEcCtD
Nabilone—Gastrointestinal pain—Niacin—atherosclerosis	0.000251	0.00213	CcSEcCtD
Nabilone—Nausea—Rosuvastatin—atherosclerosis	0.000251	0.00212	CcSEcCtD
Nabilone—Feeling abnormal—Pravastatin—atherosclerosis	0.000249	0.00211	CcSEcCtD
Nabilone—Pruritus—Ezetimibe—atherosclerosis	0.000248	0.0021	CcSEcCtD
Nabilone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000247	0.0021	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000247	0.00405	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR2—atherosclerosis	0.000247	0.00404	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—EDNRA—atherosclerosis	0.000247	0.00404	CbGpPWpGaD
Nabilone—Hypersensitivity—Simvastatin—atherosclerosis	0.000247	0.00209	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CASR—atherosclerosis	0.000246	0.00403	CbGpPWpGaD
Nabilone—Diarrhoea—Lovastatin—atherosclerosis	0.000245	0.00207	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—AGT—atherosclerosis	0.000244	0.004	CbGpPWpGaD
Nabilone—Body temperature increased—Niacin—atherosclerosis	0.000243	0.00206	CcSEcCtD
Nabilone—Abdominal pain—Niacin—atherosclerosis	0.000243	0.00206	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—GHRL—atherosclerosis	0.000241	0.00394	CbGpPWpGaD
Nabilone—Asthenia—Simvastatin—atherosclerosis	0.00024	0.00203	CcSEcCtD
Nabilone—Diarrhoea—Ezetimibe—atherosclerosis	0.00024	0.00203	CcSEcCtD
Nabilone—Abdominal pain—Pravastatin—atherosclerosis	0.000239	0.00203	CcSEcCtD
Nabilone—Body temperature increased—Pravastatin—atherosclerosis	0.000239	0.00203	CcSEcCtD
Nabilone—Pruritus—Simvastatin—atherosclerosis	0.000237	0.00201	CcSEcCtD
Nabilone—Dizziness—Lovastatin—atherosclerosis	0.000237	0.002	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000234	0.00383	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—UTS2—atherosclerosis	0.000233	0.00382	CbGpPWpGaD
Nabilone—Dizziness—Ezetimibe—atherosclerosis	0.000232	0.00197	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000232	0.0038	CbGpPWpGaD
Nabilone—Diarrhoea—Simvastatin—atherosclerosis	0.000229	0.00194	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000228	0.00374	CbGpPWpGaD
Nabilone—Vomiting—Lovastatin—atherosclerosis	0.000228	0.00193	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—EDN1—atherosclerosis	0.000227	0.00371	CbGpPWpGaD
Nabilone—Hypersensitivity—Niacin—atherosclerosis	0.000226	0.00192	CcSEcCtD
Nabilone—Rash—Lovastatin—atherosclerosis	0.000226	0.00191	CcSEcCtD
Nabilone—Dermatitis—Lovastatin—atherosclerosis	0.000225	0.00191	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CCL5—atherosclerosis	0.000225	0.00369	CbGpPWpGaD
Nabilone—Headache—Lovastatin—atherosclerosis	0.000224	0.0019	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CASR—atherosclerosis	0.000223	0.00366	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000223	0.00366	CbGpPWpGaD
Nabilone—Vomiting—Ezetimibe—atherosclerosis	0.000223	0.00189	CcSEcCtD
Nabilone—Hypersensitivity—Pravastatin—atherosclerosis	0.000223	0.00189	CcSEcCtD
Nabilone—Dizziness—Simvastatin—atherosclerosis	0.000221	0.00187	CcSEcCtD
Nabilone—Rash—Ezetimibe—atherosclerosis	0.000221	0.00187	CcSEcCtD
Nabilone—Dermatitis—Ezetimibe—atherosclerosis	0.000221	0.00187	CcSEcCtD
Nabilone—Asthenia—Niacin—atherosclerosis	0.000221	0.00187	CcSEcCtD
Nabilone—Headache—Ezetimibe—atherosclerosis	0.00022	0.00186	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000219	0.00359	CbGpPWpGaD
Nabilone—Pruritus—Niacin—atherosclerosis	0.000217	0.00184	CcSEcCtD
Nabilone—Asthenia—Pravastatin—atherosclerosis	0.000217	0.00184	CcSEcCtD
Nabilone—Pruritus—Pravastatin—atherosclerosis	0.000214	0.00181	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HRH1—atherosclerosis	0.000214	0.0035	CbGpPWpGaD
Nabilone—Vomiting—Simvastatin—atherosclerosis	0.000213	0.0018	CcSEcCtD
Nabilone—Nausea—Lovastatin—atherosclerosis	0.000213	0.0018	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—KNG1—atherosclerosis	0.000211	0.00346	CbGpPWpGaD
Nabilone—Rash—Simvastatin—atherosclerosis	0.000211	0.00179	CcSEcCtD
Nabilone—Dermatitis—Simvastatin—atherosclerosis	0.000211	0.00179	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—NFKB1—atherosclerosis	0.00021	0.00345	CbGpPWpGaD
Nabilone—Diarrhoea—Niacin—atherosclerosis	0.00021	0.00178	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—AGTR1—atherosclerosis	0.00021	0.00344	CbGpPWpGaD
Nabilone—Headache—Simvastatin—atherosclerosis	0.00021	0.00178	CcSEcCtD
Nabilone—Nausea—Ezetimibe—atherosclerosis	0.000209	0.00177	CcSEcCtD
Nabilone—Diarrhoea—Pravastatin—atherosclerosis	0.000207	0.00175	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—MAPK8—atherosclerosis	0.000207	0.00339	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL4—atherosclerosis	0.000205	0.00336	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000204	0.00333	CbGpPWpGaD
Nabilone—Dizziness—Niacin—atherosclerosis	0.000203	0.00172	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000202	0.00332	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—UTS2—atherosclerosis	0.000201	0.0033	CbGpPWpGaD
Nabilone—Dizziness—Pravastatin—atherosclerosis	0.0002	0.00169	CcSEcCtD
Nabilone—Nausea—Simvastatin—atherosclerosis	0.000199	0.00168	CcSEcCtD
Nabilone—Vomiting—Niacin—atherosclerosis	0.000195	0.00165	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000194	0.00318	CbGpPWpGaD
Nabilone—Rash—Niacin—atherosclerosis	0.000194	0.00164	CcSEcCtD
Nabilone—Dermatitis—Niacin—atherosclerosis	0.000194	0.00164	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CASR—atherosclerosis	0.000193	0.00316	CbGpPWpGaD
Nabilone—Headache—Niacin—atherosclerosis	0.000193	0.00163	CcSEcCtD
Nabilone—Vomiting—Pravastatin—atherosclerosis	0.000192	0.00163	CcSEcCtD
Nabilone—Rash—Pravastatin—atherosclerosis	0.000191	0.00162	CcSEcCtD
Nabilone—Dermatitis—Pravastatin—atherosclerosis	0.000191	0.00161	CcSEcCtD
Nabilone—Headache—Pravastatin—atherosclerosis	0.00019	0.00161	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—STAT3—atherosclerosis	0.000189	0.0031	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGT—atherosclerosis	0.000188	0.00308	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—UTS2—atherosclerosis	0.000183	0.00299	CbGpPWpGaD
Nabilone—Nausea—Niacin—atherosclerosis	0.000183	0.00155	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—MAPK3—atherosclerosis	0.000181	0.00296	CbGpPWpGaD
Nabilone—Nausea—Pravastatin—atherosclerosis	0.00018	0.00152	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CNR2—atherosclerosis	0.000179	0.00294	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000179	0.00294	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL3—atherosclerosis	0.000179	0.00292	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—EDN1—atherosclerosis	0.000178	0.00291	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCR2—atherosclerosis	0.000178	0.00291	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000178	0.00291	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL5—atherosclerosis	0.000177	0.00289	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000175	0.00287	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CASR—atherosclerosis	0.000175	0.00287	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—F2—atherosclerosis	0.000174	0.00285	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GHRL—atherosclerosis	0.000173	0.00284	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000172	0.00281	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA4—atherosclerosis	0.000168	0.00274	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRH1—atherosclerosis	0.000168	0.00274	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CNR2—atherosclerosis	0.000163	0.00267	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EDNRA—atherosclerosis	0.000161	0.00264	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCR2—atherosclerosis	0.000161	0.00264	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000161	0.00264	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00016	0.00262	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000159	0.0026	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GHRL—atherosclerosis	0.000157	0.00258	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL2—atherosclerosis	0.000155	0.00254	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL4—atherosclerosis	0.000154	0.00253	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—KNG1—atherosclerosis	0.000152	0.00249	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000151	0.00248	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGT—atherosclerosis	0.000148	0.00242	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA2—atherosclerosis	0.000144	0.00236	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL3—atherosclerosis	0.00014	0.00229	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.00014	0.00229	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCR2—atherosclerosis	0.00014	0.00229	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KNG1—atherosclerosis	0.000138	0.00226	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—UTS2—atherosclerosis	0.000138	0.00225	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGTR1—atherosclerosis	0.000137	0.00225	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—F2—atherosclerosis	0.000137	0.00224	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GHRL—atherosclerosis	0.000136	0.00223	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CX3CR1—atherosclerosis	0.000132	0.00216	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASR—atherosclerosis	0.000132	0.00216	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA4—atherosclerosis	0.000132	0.00215	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CX3CL1—atherosclerosis	0.000129	0.00212	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—EDN1—atherosclerosis	0.000128	0.0021	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCL5—atherosclerosis	0.000127	0.00208	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCR2—atherosclerosis	0.000127	0.00208	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDNRA—atherosclerosis	0.000127	0.00208	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000126	0.00207	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GHRL—atherosclerosis	0.000123	0.00202	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—atherosclerosis	0.000123	0.00201	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MMP3—atherosclerosis	0.000122	0.002	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—atherosclerosis	0.000122	0.002	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL2—atherosclerosis	0.000122	0.00199	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL4—atherosclerosis	0.000121	0.00198	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000121	0.00198	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—KNG1—atherosclerosis	0.000119	0.00195	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000119	0.00194	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EDN1—atherosclerosis	0.000116	0.00191	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL5—atherosclerosis	0.000116	0.00189	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA2—atherosclerosis	0.000113	0.00185	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PRKCG—atherosclerosis	0.00011	0.0018	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VWF—atherosclerosis	0.000109	0.00179	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOC3—atherosclerosis	0.000109	0.00178	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KNG1—atherosclerosis	0.000108	0.00177	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LDLR—atherosclerosis	0.000108	0.00177	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—UTS2—atherosclerosis	0.000108	0.00177	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGTR1—atherosclerosis	0.000108	0.00176	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGT—atherosclerosis	0.000106	0.00174	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL3—atherosclerosis	0.000105	0.00173	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CX3CR1—atherosclerosis	0.000104	0.0017	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASR—atherosclerosis	0.000104	0.0017	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CX3CL1—atherosclerosis	0.000102	0.00166	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NCF1—atherosclerosis	0.000101	0.00165	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDN1—atherosclerosis	0.000101	0.00165	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCL5—atherosclerosis	9.98e-05	0.00163	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—F2—atherosclerosis	9.83e-05	0.00161	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGT—atherosclerosis	9.66e-05	0.00158	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CNR2—atherosclerosis	9.63e-05	0.00158	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—atherosclerosis	9.62e-05	0.00158	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MMP3—atherosclerosis	9.6e-05	0.00157	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR2—atherosclerosis	9.54e-05	0.00156	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDNRA—atherosclerosis	9.54e-05	0.00156	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CYBA—atherosclerosis	9.5e-05	0.00156	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PRKCG—atherosclerosis	9.49e-05	0.00155	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.41e-05	0.00154	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLAT—atherosclerosis	9.3e-05	0.00152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GHRL—atherosclerosis	9.3e-05	0.00152	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PARP1—atherosclerosis	9.3e-05	0.00152	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDN1—atherosclerosis	9.13e-05	0.0015	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL5—atherosclerosis	9.06e-05	0.00148	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—F2—atherosclerosis	8.93e-05	0.00146	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKCG—atherosclerosis	8.62e-05	0.00141	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VWF—atherosclerosis	8.58e-05	0.0014	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—atherosclerosis	8.54e-05	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOC3—atherosclerosis	8.53e-05	0.0014	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LDLR—atherosclerosis	8.47e-05	0.00139	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGT—atherosclerosis	8.35e-05	0.00137	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL3—atherosclerosis	8.28e-05	0.00136	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KNG1—atherosclerosis	8.16e-05	0.00134	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR1—atherosclerosis	8.11e-05	0.00133	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL2—atherosclerosis	7.96e-05	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NCF1—atherosclerosis	7.93e-05	0.0013	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLG—atherosclerosis	7.9e-05	0.00129	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—F2—atherosclerosis	7.71e-05	0.00126	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGT—atherosclerosis	7.58e-05	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR2—atherosclerosis	7.49e-05	0.00123	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SOCS3—atherosclerosis	7.49e-05	0.00123	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDNRA—atherosclerosis	7.49e-05	0.00123	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CYBA—atherosclerosis	7.45e-05	0.00122	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—atherosclerosis	7.38e-05	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PARP1—atherosclerosis	7.3e-05	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GHRL—atherosclerosis	7.3e-05	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLAT—atherosclerosis	7.3e-05	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP3—atherosclerosis	7.23e-05	0.00118	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF2—atherosclerosis	7.2e-05	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—F2—atherosclerosis	7.01e-05	0.00115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOB—atherosclerosis	6.99e-05	0.00114	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—atherosclerosis	6.93e-05	0.00113	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDN1—atherosclerosis	6.88e-05	0.00113	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL5—atherosclerosis	6.82e-05	0.00112	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—atherosclerosis	6.7e-05	0.0011	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LPL—atherosclerosis	6.67e-05	0.00109	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCG—atherosclerosis	6.49e-05	0.00106	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KNG1—atherosclerosis	6.4e-05	0.00105	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR1—atherosclerosis	6.37e-05	0.00104	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SPP1—atherosclerosis	6.32e-05	0.00103	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL8—atherosclerosis	6.29e-05	0.00103	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—atherosclerosis	6.24e-05	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLG—atherosclerosis	6.2e-05	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SOCS3—atherosclerosis	5.87e-05	0.000962	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDGFB—atherosclerosis	5.85e-05	0.000957	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—atherosclerosis	5.71e-05	0.000935	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP3—atherosclerosis	5.67e-05	0.000929	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF2—atherosclerosis	5.65e-05	0.000925	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—atherosclerosis	5.59e-05	0.000916	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOE—atherosclerosis	5.59e-05	0.000916	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CAV1—atherosclerosis	5.54e-05	0.000907	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA1—atherosclerosis	5.53e-05	0.000905	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOB—atherosclerosis	5.48e-05	0.000898	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—atherosclerosis	5.44e-05	0.00089	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDN1—atherosclerosis	5.4e-05	0.000884	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL5—atherosclerosis	5.35e-05	0.000877	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ESR1—atherosclerosis	5.34e-05	0.000874	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—F2—atherosclerosis	5.27e-05	0.000864	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPL—atherosclerosis	5.24e-05	0.000857	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCG—atherosclerosis	5.09e-05	0.000834	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CG—atherosclerosis	5.05e-05	0.000827	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SPP1—atherosclerosis	4.96e-05	0.000812	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—atherosclerosis	4.94e-05	0.000808	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK3—atherosclerosis	4.83e-05	0.000792	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INS—atherosclerosis	4.78e-05	0.000782	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL2—atherosclerosis	4.7e-05	0.00077	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—atherosclerosis	4.62e-05	0.000757	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDGFB—atherosclerosis	4.59e-05	0.000751	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—atherosclerosis	4.48e-05	0.000733	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—atherosclerosis	4.39e-05	0.000719	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—atherosclerosis	4.39e-05	0.000719	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—atherosclerosis	4.39e-05	0.000719	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CAV1—atherosclerosis	4.35e-05	0.000712	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA1—atherosclerosis	4.34e-05	0.00071	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ESR1—atherosclerosis	4.19e-05	0.000686	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—atherosclerosis	4.19e-05	0.000686	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—F2—atherosclerosis	4.14e-05	0.000678	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—atherosclerosis	3.96e-05	0.000649	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK3—atherosclerosis	3.79e-05	0.000621	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INS—atherosclerosis	3.75e-05	0.000614	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—atherosclerosis	3.72e-05	0.000609	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—atherosclerosis	3.69e-05	0.000604	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—atherosclerosis	3.63e-05	0.000594	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—atherosclerosis	3.59e-05	0.000588	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—atherosclerosis	3.53e-05	0.000579	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—atherosclerosis	3.44e-05	0.000564	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—atherosclerosis	3.36e-05	0.00055	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NFKB1—atherosclerosis	3.33e-05	0.000545	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—atherosclerosis	3.29e-05	0.000538	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK8—atherosclerosis	3.27e-05	0.000535	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—atherosclerosis	3.26e-05	0.000534	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—atherosclerosis	3.02e-05	0.000494	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—atherosclerosis	2.99e-05	0.000489	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—atherosclerosis	2.92e-05	0.000478	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—atherosclerosis	2.86e-05	0.000468	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—atherosclerosis	2.82e-05	0.000461	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—atherosclerosis	2.77e-05	0.000454	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—atherosclerosis	2.77e-05	0.000454	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—atherosclerosis	2.64e-05	0.000432	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NFKB1—atherosclerosis	2.61e-05	0.000427	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK8—atherosclerosis	2.57e-05	0.00042	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—atherosclerosis	2.56e-05	0.000419	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—atherosclerosis	2.37e-05	0.000388	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—atherosclerosis	2.35e-05	0.000384	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—atherosclerosis	2.24e-05	0.000367	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—atherosclerosis	2.17e-05	0.000356	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—atherosclerosis	2.09e-05	0.000342	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—atherosclerosis	1.93e-05	0.000315	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—atherosclerosis	1.64e-05	0.000268	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—atherosclerosis	1.51e-05	0.000247	CbGpPWpGaD
